mTORC1 inhibitor rapamycin was reported to inhibit the TGF-β-induced differentiation of corneal myofibroblasts, and ameliorated renal fibrosis in lupus nephritis by decreased anti-dsDNA antibody triggered downstream inflammatory and fibrotic processes [33, 75]. This evidence concerns the gene TGFB1 and lupus nephritis.